{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:40:21Z","timestamp":1787319621019,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1097\/md.0000000000005577","type":"journal-article","created":{"date-parts":[[2016,12,8]],"date-time":"2016-12-08T10:19:07Z","timestamp":1481192347000},"page":"e5577","source":"Crossref","is-referenced-by-count":9,"title":["Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis"],"prefix":"10.1097","volume":"95","author":[{"given":"Yuechun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-68-20210226","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1161\/01.STR.31.11.2628","article-title":"Predictors of cerebrovascular events and death among patients with valvular heart disease: a population-based study","volume":"31","author":"Petty","year":"2000","journal-title":"Stroke"},{"key":"R2-68-20210226","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.014807","article-title":"Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"132","author":"Avezum","year":"2015","journal-title":"Circulation"},{"key":"R3-68-20210226","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-140-2-200401200-00010","article-title":"Resolution of left atrial thrombus after 6 months of anticoagulation in candidates for percutaneous transvenous mitral commissurotomy","volume":"140","author":"Silaruks","year":"2004","journal-title":"Ann Intern Med"},{"key":"R4-68-20210226","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"R5-68-20210226","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ahj.2016.05.007","article-title":"Left atrial thrombus resolution in atrial fibrillation or flutter: results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"178","author":"Lip","year":"2016","journal-title":"Am Heart J"},{"key":"R6-68-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9149(97)00858-8","article-title":"Comparison of outcomes of percutaneous mitral valvuloplasty versus mitral valve replacement after resolution of left atrial appendage thrombi by warfarin therapy","volume":"81","author":"Kang","year":"1998","journal-title":"Am J Cardiol"},{"key":"R7-68-20210226","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11239-012-0747-1","article-title":"Dabigatran and left atrial appendage thrombus","volume":"34","author":"Vidal","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"R8-68-20210226","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000354315","article-title":"Dissolution of the left atrial appendage thrombus with rivaroxaban therapy","volume":"36","author":"Takasugi","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"R9-68-20210226","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1160\/TH12-11-0821","article-title":"Resolution of giant left atrial appendage thrombus with rivaroxaban","volume":"109","author":"Hammerstingl","year":"2013","journal-title":"Thromb Haemost"},{"key":"R10-68-20210226","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/eht148","article-title":"Dabigatran for left atrial thrombus","volume":"34","author":"Morita","year":"2013","journal-title":"Eur Heart J"},{"key":"R11-68-20210226","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-9560-11-26","article-title":"Resolution of left atrial appendage thrombus with apixaban","volume":"11","author":"Kawakami","year":"2013","journal-title":"Thromb J"},{"key":"R13-68-20210226","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.11.031","article-title":"Embolic stroke during apixaban therapy for left atrial appendage thrombus","volume":"24","author":"Ohyagi","year":"2015","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R14-68-20210226","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/eurheartj\/ehv081","article-title":"Large protruding thrombus over left atrial appendage occlusion device successfully treated with apixaban","volume":"36","author":"Freixa","year":"2015","journal-title":"Eur Heart J"},{"key":"R15-68-20210226","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijcard.2016.03.147","article-title":"Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus","volume":"214","author":"Eftekhari","year":"2016","journal-title":"Int J Cardiol"},{"key":"R16-68-20210226","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3904\/kjim.2015.131","article-title":"Series with complete resolution of left atrial appendage thrombi with apixaban in elderly patients","volume":"31","author":"Lee","year":"2016","journal-title":"Korean J Intern Med"},{"key":"R17-68-20210226","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.joa.2016.01.009","article-title":"Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban","volume":"32","author":"Miwa","year":"2016","journal-title":"J Arrhythm"},{"key":"R18-68-20210226","first-page":"430","article-title":"Rivaroxaban twice daily for lysis of left atrial appendage thrombus: a potential new therapeutic option","volume":"126","author":"Piotrowski","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"R19-68-20210226","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ahj.2014.12.020","article-title":"Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial\/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF)","volume":"169","author":"Lip","year":"2015","journal-title":"Am Heart J"},{"key":"R20-68-20210226","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2012.11.029","article-title":"Whole blood clots are more resistant to lysis than plasma clots\u2014greater efficacy of rivaroxaban","volume":"131","author":"Varin","year":"2013","journal-title":"Thromb Res"},{"key":"R21-68-20210226","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.STR.21.11.1540","article-title":"Regression of intracardiac thrombus after embolic stroke","volume":"21","author":"Yasaka","year":"1990","journal-title":"Stroke"},{"key":"R22-68-20210226","first-page":"313","article-title":"Left atrial thrombus under dabigatran in a patient with nonvalvular atrial fibrillation","volume":"74","author":"Janssen","year":"2016","journal-title":"Neth J Med"},{"key":"R23-68-20210226","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"R24-68-20210226","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R25-68-20210226","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"R26-68-20210226","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R27-68-20210226","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"R28-68-20210226","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1093\/eurheartj\/ehu305","article-title":"Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial","volume":"35","author":"Breithardt","year":"2014","journal-title":"Eur Heart J"},{"key":"R29-68-20210226","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.115.020950","article-title":"Comparison of dabigatran and warfarin in patients with atrial fibrillation and valvular heart disease: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulant Therapy)","volume":"134","author":"Ezekowitz","year":"2016","journal-title":"Circulation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:39:15Z","timestamp":1620945555000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201612060-00068"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":28,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005577","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}